Skip to main content

Table 5 Dose intensity according to decrease in renal function

From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients

  Group D
(n = 13)
Group ND
(n = 27)
p-value
Initial dose (mg) 24
Time (months) n DI (mg/day) n DI (mg/day)  
12 13 11.9 (7.6–13.7) 27 11.6 (4–18.1) 0.7507
24 13 9.7 (6–14) 24 9.8 (6.7–16.4) 0.4640
36 10 9.2 (5.2–13) 14 9 (7.2–13.2) 0.8836
48 6 8 (4.5–10.5) 7 8.7 (6.3–10.1) 0.7751
60 4 7.4 (4.1–10.5) 6 9.05 (5.6–9.8) 0.6698